We have demonstrated that IDO-reactive CD8+ T cells were peptide-specific, cytotoxic effector cells, which are able to recognize and kill IDO-expressing cells including tumor cells as well as dendritic cells. The gene discussed is IDO1; the disease is neoplasm.